Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "City"

1536 News Found

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD
People | July 18, 2022

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD

Manish led SeQuent since 2014 and played a major role in transforming the company


Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
News | July 18, 2022

Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’

Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru


Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
News | July 16, 2022

Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA

ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.


HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network
People | July 16, 2022

HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network

Mittal will be driving expansion of the provider network across India


CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
News | July 15, 2022

CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine

Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.


Bajaj Healthcare forays into the highly regulated - Opiate Processing Business for the GOI
Healthcare | July 14, 2022

Bajaj Healthcare forays into the highly regulated - Opiate Processing Business for the GOI

The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.


Sirio Pharma announces agreement to acquire best formulations
News | July 10, 2022

Sirio Pharma announces agreement to acquire best formulations

The combined company will be able to better serve both our global and regional customers with local production


WuXi STA opens Oligonucleotide and Peptide manufacturing facility
News | July 08, 2022

WuXi STA opens Oligonucleotide and Peptide manufacturing facility

Site Enhances New Modality CRDMO Platform Capacity for Customers


Lonza to build large-scale fill & finish facility in Switzerland
News | July 07, 2022

Lonza to build large-scale fill & finish facility in Switzerland

The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026


Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine
News | July 06, 2022

Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine

Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells